Search

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

… Monday, September 17, 2018 Summary Precision oncology is based on the idea that people can be treated according to the genetic changes that cause a tumor to grow and spread. At Memorial Sloan Kettering, this area of medicine is helping both children and adults. Here, pediatric sarcoma specialist Filemon

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

… Monday, September 9, 2013 Summary Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable. A new international study led by physicians and scientists from Memorial Sloan Kettering has discovered a gene mutation linked

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.

… Monday, December 15, 2025 In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system’s ability to fight against a tumor. Colorectal cancer, however, is a puzzling exception. A high density of Treg cells in colorectal tumors

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.

… Tuesday, February 4, 2020 Summary Larry Norton, Senior Vice President at Memorial Sloan Kettering, discusses some of the biggest achievements in cancer care made between 2010 and 2019, and what he hopes to see next. In January, the American Cancer Society reported that the rate of cancer deaths in the

Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells.

… Monday, October 6, 2025 Understanding the interaction between immune cells and cancer cells has important implications for  cancer immunotherapies , including  checkpoint inhibitor drugs and cell-based therapies, as well as newer treatments like  cancer vaccines . Over the last decade,  computational

Isabel Lam, a 2016 alumnae of Gerstner Sloan Kettering, has been awarded the Chairman’s Prize for her first-author paper “Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast,” published in Science in 2015.

… Friday, July 29, 2016 Isabel Lam , a 2016 alumnae of Gerstner Sloan Kettering, has been awarded the Chairman’s Prize for her first-author paper “ Nonparadoxical evolutionary stability of the recombination initiation landscape in yeast ,” published in Science in 2015. Isabel completed her graduate research

Sixth-year graduate student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper accepted for publication in the January 28, 2012 issue of Science.

… Wednesday, August 15, 2012 Sixth-year student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper “Crystal Structure of the Human Two-Pore Domain Potassium Channel K2P1,” published in the journal Science on January 26, 2012 . The study, which revealed the three-dimensional shape

Memorial Sloan Kettering Cancer Center today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.

… Friday, March 14, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. The new building has been thoughtfully designed to meet

Why endometrial cancer is especially dangerous for Black women.

… Monday, June 10, 2024 The numbers are stark and deeply troubling. Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than 66,000

Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months.

… Monday, December 14, 2020 Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months, according to a retrospective study of 18 cancer patients treated